ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.
FASEB J. 2019 Dec;33(12):14825-14840. doi: 10.1096/fj.201901440RR. Epub 2019 Oct 31.
FASEB J. 2019.
PMID: 31670977